Idalopirdine, which is being developed with Japan’s Otsuka Pharmaceutical Co Ltd, is being tested in patients with mild to moderate Alzheimer’s disease.
Posted on 22 September 2016.
Idalopirdine, which is being developed with Japan’s Otsuka Pharmaceutical Co Ltd, is being tested in patients with mild to moderate Alzheimer’s disease.
Posted in Health studiesComments (0)